Rexall Antibiotic Ointment
NDC Package 55910-536-64

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Rexall Antibiotic (bacitracin) ointment is a medication an antibiotic used to treat certain bacterial eye infections. This formulation utilizes a ointment delivery system. Marketed by Dolgencorp, Llc, this product is identified by NDC 55910-536 and is authorized under FDA application M004.

Identification & Billing

NDC Package Code
55910-536-64
Package Description
1 TUBE in 1 CARTON / 28 g in 1 TUBE
Product Code
55910-536
11-Digit Billing Format
55910053664
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Rexall Antibiotic
Non-Proprietary Name
Bacitracin
Substance Name
Bacitracin
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BACITRACIN 500 [USP'U]/g
Pharmacologic Class
Decreased Cell Wall Synthesis & Repair - [PE] (Physiologic Effect)
Usage Information
This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Regulatory & Marketing

Labeler Name
Dolgencorp, Llc
Product Type
Human Otc Drug
FDA Application #
M004
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-22-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55910-536-64 identifies a specific commercial package of 1 tube in 1 carton / 28 g in 1 tube of Rexall Antibiotic, a human over the counter drug labeled by Dolgencorp, Llc. This ointment is formulated for topical use and contains bacitracin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dolgencorp, Llc on September 22, 2015. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

How is this Dolgencorp, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910053664. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55910-536-64
11-Digit CMS (5-4-2)
55910-0536-64

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.